OverviewSuggest Edit

Vitrolife is a biotechnology company that develops products to counter fertility issues in humans. The Сompany also develops various media that enable researchers and cell therapy companies to use cells for therapeutic purposes.
TypePublic
Founded1981
HQVästra Frölunda, SE
Websitevitrolife.com
Employee Ratings3.8

Latest Updates

Employees (est.) (Sept 2020)418
Share Price (Oct 2020)KR220.6 (-1%)
Cybersecurity ratingCMore

Vitrolife Office Locations

Vitrolife has an office in Västra Frölunda
Västra Frölunda, SE (HQ)
Gustaf Werners gata 2
Show all (1)

Vitrolife Financials and Metrics

Vitrolife Revenue

Market capitalization (15-Oct-2020)

23.9b

Closing stock price (15-Oct-2020)

220.6
Vitrolife's current market capitalization is kr23.9 b.
Show all financial metrics

Vitrolife Cybersecurity Score

Cybersecurity ratingPremium dataset

C

73/100

SecurityScorecard logo

Vitrolife Online and Social Media Presence

Embed Graph

Vitrolife News and Updates

Assisted Reproductive Technology Market By Top Leading Players : Ferring B.V., OvaScience, Inc, KITAZATO CORPORATION., Vitrolife, CooperSurgical Inc.

The "Global Assisted Reproductive Technology Market Analysis to 2025" is a specialized and in-depth study of the medical device industry with a focus on the global market trend. The report aims to provide an overview of global assisted reproductive technology market with detailed market segmentation…

Vitrolife Blogs

The value of a true partnership – a story from Aleris-Hamlet Fertility, Copenhagen, Denmark

What do you as an IVF professional look for when setting up an entirely new clinic and laboratory? For the laboratory manager, Helle Bendtsen at Aleris-Hamlet Fertility in Copenhagen, the advantage of having one supplier for all of their procedures in the laboratory was clear quite quick…

We Love Symbols

“A picture is worth a thousand words” – this old proverb is embraced and applied by medical device manufacturers all around the world, but why is that?The answer to that question starts with the fact that most countries’ health authorities require medical device manufacturers to provide …

New publication: Automatic grading of human blastocysts from time-lapse imaging

Blastocyst grading is known to be highly subjective and without the use of time-lapse can result in an incorrect evaluation of collapsed or partially collapsed blastocysts. Artificial intelligence has the potential to make processes in IVF more precise, consistent and efficient in the fu…

Amino Acids and ART

For most people, amino acids are synonymous with protein and DNA synthesis and their ability to act as substrates for energy production, and relatively little else. Over the past two decades however we have developed a very different appreciation for amino acids and the highly diverse ro…

Thoughts and reflections from ASRM 2019

This year Philadelphia hosted the annual American Society for Reproductive Medicine meeting for thousands of delegates from all over the world. Similar to previous years, IVF professionals gathered to present or listen to the latest scientific developments in the field of assisted reprod…

The road to successful ICSI

Different assisted fertilisation methods were developed and implemented in the field of IVF during 1980-1990. Out of these methods, intracytoplasmic sperm injection (ICSI) is the most successful method developed1 and is considered to be one of the major breakthroughs in this field since …
Show more

Vitrolife Frequently Asked Questions

  • When was Vitrolife founded?

    Vitrolife was founded in 1981.

  • How many employees does Vitrolife have?

    Vitrolife has 418 employees.

  • Who are Vitrolife competitors?

    Competitors of Vitrolife include PamBio, Immage Biotherapeutics and Yumanity Therapeutics.

  • Where is Vitrolife headquarters?

    Vitrolife headquarters is located at Gustaf Werners gata 2, Västra Frölunda.

  • Where are Vitrolife offices?

    Vitrolife has an office in Västra Frölunda.

  • How many offices does Vitrolife have?

    Vitrolife has 1 office.